Private Label Niacinamide Zinc Spot Gel Manufacturer Low MOQ

What claims can I legally make for a niacinamide zinc spot gel?

By Blake Mereby · Last reviewed October 4, 2026

Claim strategy for a niacinamide zinc spot gel is one of the most legally consequential decisions a brand makes before launch, because the line between a permissible cosmetic claim and an illegal drug claim in the US — or a claim requiring clinical substantiation in the EU — is crossed more easily than most founders realise.

In the United States, the FDA regulates products as cosmetics, drugs, or both, based primarily on the product's intended use as communicated by claims, labelling, website copy, and even social media statements. A niacinamide zinc gel is a cosmetic if it is intended to cleanse, beautify, or alter appearance. It becomes a drug if it is intended to treat, cure, mitigate, or prevent a disease (including acne as a skin disease) or to affect the structure or function of the body beyond appearance. Permissible cosmetic claims include: "visibly reduces the appearance of blemishes," "helps minimise the look of pores," "mattifies skin," "brightens the look of post-blemish marks," and "leaves skin looking clearer." Prohibited drug-territory claims include: "treats acne," "kills acne-causing bacteria," "prevents breakouts," and "heals blemishes." The words "treat," "heal," "prevent," "cure," and "fight" are consistent red flags.

Niacinamide is not an FDA-approved OTC drug monograph ingredient for acne. If you use it with drug claims, you are marketing an unapproved new drug — a serious regulatory violation. Zinc acetate at 0.25% is an approved OTC acne-treatment active under the monograph, but using it in a drug product triggers the full OTC drug compliance framework: specific labelling format, drug facts panel, facility registration as a drug manufacturer, and listing with the FDA NDC directory.

In the European Union, claims must comply with EU Cosmetics Regulation Annex III restrictions and the Common Criteria for claims (Regulation 655/2013). Claims must be truthful, evidenced, and not misleading. The EU takes a strong stance against claims that imply medical efficacy. You need documented substantiation (in vitro data, consumer perception studies, or published literature) for any efficacy claim. Claims referencing clinical studies must accurately represent those studies and not overstate results.

In the UK post-Brexit, the UK Cosmetics Regulation mirrors EU rules but is administered separately — register your product on the UK Cosmetics Product Notification Portal (SCPN) before placing it on the UK market.

Practical guidance: have a regulatory consultant or qualified IP attorney review your label, website, and social copy before launch. Manufacturers on the AJ Cosmo Labs platform can often refer brands to regulatory partners experienced in cosmetic claim substantiation, which can save significant cost versus engaging a large regulatory law firm from scratch.

Ingredients in this answer: Niacinamide

Read the full guide on Private Label Niacinamide Zinc Spot Gel Manufacturer Low MOQ →

More about Private Label Niacinamide Zinc Spot Gel Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app